SYNGENE INTERNATIONAL Financial Statement Analysis
|
||
The Revenues of SYNGENE INTERNATIONAL have increased by 19.22% YoY .
The Earnings Per Share (EPS) of SYNGENE INTERNATIONAL has increased by 17.11 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
SYNGENE INTERNATIONAL Last 5 Annual Financial Results
[BOM: 539268|NSE : SYNGENE]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹2,604 Cr | ₹2,184 Cr | ₹2,012 Cr | ₹1,826 Cr | ₹1,423 Cr |
Expenses | ₹1,864 Cr | ₹1,531 Cr | ₹1,409 Cr | ₹1,290 Cr | ₹1,033 Cr |
Operating Profit (Excl OI) | ₹741 Cr | ₹653 Cr | ₹603 Cr | ₹536 Cr | ₹391 Cr |
Other Income | ₹108 Cr | ₹83 Cr | ₹96 Cr | ₹76 Cr | ₹136 Cr |
Interest | ₹24 Cr | ₹28 Cr | ₹35 Cr | ₹32 Cr | ₹23 Cr |
Depreciation | ₹310 Cr | ₹275 Cr | ₹219 Cr | ₹164 Cr | ₹131 Cr |
Profit Before Tax | ₹484 Cr | ₹469 Cr | ₹517 Cr | ₹415 Cr | ₹373 Cr |
Profit After Tax | ₹396 Cr | ₹405 Cr | ₹412 Cr | ₹332 Cr | ₹305 Cr |
Consolidated Net Profit | ₹396 Cr | ₹405 Cr | ₹412 Cr | ₹332 Cr | ₹305 Cr |
Earnings Per Share (Rs) | ₹11.57 | ₹9.88 | ₹10.12 | ₹10.30 | ₹16.58 |
PAT Margin (%) | 14.54 | 15.20 | 18.54 | 20.48 | 18.16 |
ROE(%) | 13.73 | 13.29 | 16.59 | 20.21 | 18.26 |
ROCE(%) | 15.43 | 13.24 | 15.40 | 19.60 | 16.98 |
Total Debt/Equity(x) | 0.16 | 0.25 | 0.28 | 0.32 | 0.41 |
Key Financials |
||
Market Cap | : | ₹ 27,404.3 Cr |
Revenue (TTM) | : | ₹ 3,566.1 Cr |
Net Profit(TTM) | : | ₹ 500.1 Cr |
EPS (TTM) | : | ₹ 12.4 |
P/E (TTM) | : | 54.8 |
Industry Peers & Returns | 1W | 1M | 1Y |
SYNGENE INTERNATIONAL | -1.6% | -10.8% | 16.2% |
BLS INTERNATIONAL SERVICES | 2.7% | -7% | 126.5% |
LATENT VIEW ANALYTICS | -7.4% | -14.2% | 35.7% |
QUESS CORP | 0.8% | -0.4% | 39.6% |
DELTA CORP | -4.2% | -11.9% | -34.5% |
SUN PHARMA ADVANCED RESEARCH COMPANY | -3.6% | 0.7% | 92.3% |
SECURITY AND INTELLIGENCE SERVICES INDIA | -1.4% | 1% | 27.6% |
JUST DIAL | -6.6% | -8.5% | 33.5% |
TEAMLEASE SERVICES | -3.1% | -11.1% | 16.4% |
SYNGENE INTERNATIONAL Revenues
[BOM: 539268|NSE : SYNGENE]
Y-o-Y | 19.22 % |
5 Yr CAGR | 16.31 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹2,604 Cr | 19.22 | |
Mar2022 | ₹2,184 Cr | 8.57 | |
Mar2021 | ₹2,012 Cr | 10.20 | |
Mar2020 | ₹1,826 Cr | 28.28 | |
Mar2019 | ₹1,423 Cr | - |
SYNGENE INTERNATIONAL Operating Profit
[BOM: 539268|NSE : SYNGENE]
Y-o-Y | 13.38 % |
5 Yr CAGR | 17.35 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹741 Cr | 13.38 | |
Mar2022 | ₹653 Cr | 8.24 | |
Mar2021 | ₹603 Cr | 12.64 | |
Mar2020 | ₹536 Cr | 37.18 | |
Mar2019 | ₹391 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -4.92 % |
5 Yr CAGR | 0.89 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 28.43% | -4.92 | |
Mar2022 | 29.9% | -0.30 | |
Mar2021 | 29.99% | 2.22 | |
Mar2020 | 29.34% | 6.92 | |
Mar2019 | 27.44% | - |
SYNGENE INTERNATIONAL Profit After Tax
[BOM: 539268|NSE : SYNGENE]
Y-o-Y | -2.25 % |
5 Yr CAGR | 6.70 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹396 Cr | -2.25 | |
Mar2022 | ₹405 Cr | -1.75 | |
Mar2021 | ₹412 Cr | 24.28 | |
Mar2020 | ₹332 Cr | 8.58 | |
Mar2019 | ₹305 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -4.34 % |
5 Yr CAGR | -5.41 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 14.54 % | -4.34 | |
Mar2022 | 15.2 % | -18.02 | |
Mar2021 | 18.54 % | -9.47 | |
Mar2020 | 20.48 % | 12.78 | |
Mar2019 | 18.16 % | - |
SYNGENE INTERNATIONAL Earnings Per Share (EPS)
[BOM: 539268|NSE : SYNGENE]
Y-o-Y | 17.11 % |
5 Yr CAGR | -8.60 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹12 | 17.11 | |
Mar2022 | ₹9.88 | -2.37 | |
Mar2021 | ₹10 | -1.75 | |
Mar2020 | ₹10 | -37.88 | |
Mar2019 | ₹17 | - |
SYNGENE INTERNATIONAL Return on Capital Employed (ROCE)
[BOM: 539268|NSE : SYNGENE]
Y-o-Y | 16.54 % |
5 Yr CAGR | -2.36 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 15.43% | 16.54 | |
Mar2022 | 13.24% | -14.03 | |
Mar2021 | 15.4% | -21.43 | |
Mar2020 | 19.6% | 15.43 | |
Mar2019 | 16.98% | - |
SYNGENE INTERNATIONAL Share Price vs Sensex
Current Share Price | : | ₹681.7 |
Current MarketCap | : | ₹ 27,404.3 Cr |
Updated EOD on | : | Mar 18,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNGENE INTERNATIONAL | -1.6% |
-10.8% |
16.2% |
SENSEX | -1% |
1% |
24.9% |
SYNGENE INTERNATIONAL related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE 200 | -1.9% | -0.1% | 35.3% |
S&P BSE 250 LARGEMIDCAP | -2% | -0.4% | 35.3% |
S&P BSE HEALTHCARE | -2.1% | -2.4% | 59.2% |
S&P BSE 500 | -2.2% | -0.9% | 36.5% |
S&P BSE ALLCAP | -2.3% | -1.4% | 38% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY 200 | -2% | -0.3% | 35.5% |
NIFTY HEALTHCARE | -2.1% | -1% | 59.4% |
NIFTY 500 | -2.2% | -1% | 37.3% |
NIFTY LARGE MIDCAP 250 | -2.7% | -1.8% | 41.9% |
NIFTY500 MULTICAP 50:25:25 | -2.8% | -2.6% | 43% |
You may also like the below Video Courses
FAQ about SYNGENE INTERNATIONAL Financials
How the annual revenues of SYNGENE INTERNATIONAL have changed ?
The Revenues of SYNGENE INTERNATIONAL have increased by 19.22% YoY .
How the Earnings per Share (EPS) of SYNGENE INTERNATIONAL have changed?
The Earnings Per Share (EPS) of SYNGENE INTERNATIONAL has increased by 17.11 % YoY .
SYNGENE INTERNATIONAL LTD vs BLS INTERNATIONAL SERVICES LTD vs LATENT VIEW ANALYTICS LTD
QUESS CORP LTD vs DELTA CORP LTD vs